Article
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study.
Microbial drug resistance (Larchmont, N.Y.) - 1 Apr 2016
Djennane-Hadibi Fazia, Bachtarzi Mohamed, Layaida Karim, Ali Arous Nassima, Nakmouche Mhamed, Saadi Berkane, Tazir Mohamed, Ramdani-Bouguessa Nadjia, Burucoa Christophe
Abstract excerpt
Knowledge of local antibiotic resistance is crucial to adaptation for the choice of the optimal first-line treatment for Helicobacter pylori infection. Clarithromycin is a key component of the standard triple therapy largely used worldwide and, more particularly, in Algeria. Clarithromycin resistance is the main risk factor for treatment failure. The aim of this study was to evaluate, for the first time in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
